Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation factor A1 pseudogene 4 (TCEA1P4) is a processed pseudogene related to the *TCEA1* gene, which encodes transcription elongation factor A1, a protein involved in facilitating transcription by RNA polymerase II[1]. Pseudogenes like TCEA1P4 originate from duplication or retrotransposition events but lack the capacity to produce functional proteins due to mutations or lack of regulatory elements required for expression[1]. These loci are considered non-functional genomic DNA and are not relevant as direct drug targets, disease markers, or biological effectors. The TCEA1 gene encodes a protein involved in transcriptional elongation but TCEA1P4 itself encodes no functional product. Pseudogenes may sometimes regulate expression of their parent genes through RNA-based mechanisms, but no such function is established for TCEA1P4[1]. If you want information on the functional gene (TCEA1), or on elongation factors involved in transcription, these would be legitimate protein targets, unlike TCEA1P4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription elongation factor A1 pseudogene 4 (TCEA1P4).